Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

CNBCMay 29, 2026 at 3:10 AM

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

markets

Two months, $2.6 billion: How NASA ETF turned SpaceX IPO access into a hot retail trade

CNBCMay 30, 2026 at 3:33 PM

markets

America is losing the AI productivity war to 3.5 million Chinese STEM graduates

MarketWatchMay 30, 2026 at 6:36 PM

markets

As Big Tech’s power demand surges, data centers bring utilities a huge new profit center

MarketWatchMay 30, 2026 at 6:56 PM

← Back to all articles

Related Articles

Two months, $2.6 billion: How NASA ETF turned SpaceX IPO access into a hot retail trade

America is losing the AI productivity war to 3.5 million Chinese STEM graduates

As Big Tech’s power demand surges, data centers bring utilities a huge new profit center